Registration now open
INHSU 2024 will bring together hundreds of global attendees from sectors including harm reduction, infectious diseases, civil society, and drug policy. This event promises to foster collaborative dialogue and catalyse positive change for marginalised communities worldwide.
WHY ATTEND?
INHSU conferences are unique due to the cross-collaboration between different stakeholders dedicated to the health of people who use drugs. People who use drugs, advocates, health care providers, program managers, harm reduction experts, researchers, and policymakers each have an equal voice, leading to a program that facilitates balanced discussions and shared perspectives.
Niklas Luhmann, WHO
Dr Vana Sypsa, University of Athens
Tracey Brown, Justice Health NSW
Roberto Perez, C-EHRN
PREVIOUS SPEAKERS
INHSU 2024 will feature over 100+ sessions on hepatitis C and other infectious diseases, harm reduction and drug policy. There will be tracks on epidemiology and public health research, clinical research, social science and policy research, and good practice models of care for people who use drugs.